StockData
Clover Health Investments, Corp. logo

Clover Health Investments, Corp. (CLOV) stock

CLOVNasdaqHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$4.73−0.22 (-4.44%)

Close on Nov 17, 2026Market cap $2.51BP/E –Yield –

Clover Health Investments free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Clover Health Investments's free cash flow for the twelve months ending Jun 30, 2026 was $74.21M. For fiscal 2025 it was -$68.98M, down 307.2% from the year before. The highest annual figure on record is $33.29M in fiscal 2024.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$68.98M-307.2%
FY2024Dec 31, 2024$33.29M–
FY2023Dec 31, 2023-$145.25M–
FY2022Dec 31, 2022-$208.39M–
FY2021Dec 31, 2021-$283.05M–
FY2020Dec 31, 2020-$119.19M–
FY2019Dec 31, 2019-$159.90M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$24.51M+406.4%
Q1 FY2026Mar 31, 2026$107.04M–
Q4 FY2025Dec 31, 2025-$68.75M–
Q3 FY2025Sep 30, 2025$11.41M-77.0%
Q2 FY2025Jun 30, 2025$4.84M-89.1%
Q1 FY2025Mar 31, 2025-$16.48M-164.6%
Q4 FY2024Dec 31, 2024-$86.15M–
Q3 FY2024Sep 30, 2024$49.59M–
Q2 FY2024Jun 30, 2024$44.36M-16.0%
Q1 FY2024Mar 31, 2024$25.49M-67.6%
Q4 FY2023Dec 31, 2023-$257.82M–
Q3 FY2023Sep 30, 2023-$19.02M-118.8%
Q2 FY2023Jun 30, 2023$52.82M–
Q1 FY2023Mar 31, 2023$78.78M–
Q4 FY2022Dec 31, 2022-$213.25M–
Q3 FY2022Sep 30, 2022$101.40M–
Q2 FY2022Jun 30, 2022-$39.34M–
Q1 FY2022Mar 31, 2022-$57.20M–
Q4 FY2021Dec 31, 2021-$80.41M–
Q3 FY2021Sep 30, 2021-$45.32M–
Q2 FY2021Jun 30, 2021-$64.35M-594.6%
Q1 FY2021Mar 31, 2021-$92.97M–
Q4 FY2020Dec 31, 2020-$59.97M–
Q3 FY2020Sep 30, 2020-$34.82M–
Q2 FY2020Jun 30, 2020$13.01M–
Q1 FY2020Mar 31, 2020-$37.42M–

More Clover Health Investments figures

See a number that looks wrong?